Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // April 29th, 2011 // 7:11 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Alliance Life Sciences hired Animesh Gandhi as a director on aggregate spend, which refers to the state and federal reporting process for payments to healthcare professionals. Previously, Gandhi worked as a management consultant at Daiichi Sankyo and held positions at EMC and marketRx.
Savient Pharma hired Richard Crowley as exec vp of biopharma operations;
Healthcare Data Solutions hired Jeff Shippen as vp database group;
The Medicines Company added John Kelly to its board;
Pharmanet Development hired Valerie Palumbo as sr vp corporate quality assurance;
Ligand Pharmaceuticals hired Matthew Foehr as exec vp and chief operating officer;
Genmab hired Rachel Curtis Gravesen as sr vp investor relations;
Icagen promoted Douglas Krafte to chief scientific officer;
Novavax named Louis Fries III vp of clinical and medical affairs;
Acucela hired David Lowrance as cfo;
Alimera Sciences added Glen Bradley to its board;
Protect Pharmaceutical named Ramesha Sesha as ceo;
Mersana Therapeutics named Michael Metzger exec vp and chief operating officer;
GenMark Diagnostics hired Sue Pierce as vp, product development;
Acura Pharma ceo Andy Reddick is on a leave of absence for health reasons;
Threshold Pharma hired Samuel Saks as chief medical officer on an interim basis;
Prescription Solutions hired Brian Solow as chief medical officer;
SynapDx added Thomas Mac Mahon to its board;
Aegerion Pharmaceuticals added Sol Barer to its board;
Diamyd ceo Elisabeth Linder stepped down as ceo after disagreements with the board;
Diamyd named Peter Zerhouni as acting ceo;
Cellceutix added patent attorney Paul Ginsburg to its advisory board;
Regulus Therapeutics hired Neil Gibson as chief scientific officer;
Tongli Pharmaceuticals added Stephen Sax to its board;
Biomedical Research Alliance of New York hired Maureen Hurst GCP compliance auditor;
Biomedical Research Alliance of New York hired Alexi Morillo as program director for Medicare coverage analysis.
Ladder shot thx to Robert CB on Flickr Creative Commons
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Acucela, Acura Pharmaceuticals, Aegerion Pharmaceuticals, Alliance Life Sciences, Biomedical Research Alliance of New York, BRANY, Cellceutix, Diamyd, Genmab, GenMark Diagnostics, Healthcare Data Solutions, Icagen, Ligand Pharmaceuticals, Mersana Therapeutics, Novavax, PharmaNet Development, Protect Pharmaceutical, Regulus Therapeutics, Savient Pharmaceuticals, SynapDx, The Medicines Company, Thershold Pharmaceuticals, Tongli Pharmaceuticals